[Home](https://github.com/mm80843/T3.5/blob/main/docs/index.md) >> Class: [Risk](https://github.com/mm80843/T3.5/tree/main/docs/Risk/index.md) >> Individual ID:PBN__Risk_466 

# __Slow drug development__

## Category to which it belongs

* [The challenges include reduced surgical education, loss of control, limited diagnostics, slow drug development, inadequate patient monitoring, and lack of drug therapy options.](https://github.com/mm80843/T3.5/blob/main/docs/PBNCategory/PBN__PBNCategory_110.md)

## Closest similar item

* [Delayed drug development](https://github.com/mm80843/T3.5/blob/main/docs/Risk/PBN__Risk_1801.md)
* [Development of drugs](https://github.com/mm80843/T3.5/blob/main/docs/Risk/PBN__Risk_431.md)
* [Lack of effective drugs](https://github.com/mm80843/T3.5/blob/main/docs/Risk/PBN__Risk_2724.md)
* [Lack of effective pharmaceutical response](https://github.com/mm80843/T3.5/blob/main/docs/Risk/PBN__Risk_1602.md)
* [Slowed development, lack of progress](https://github.com/mm80843/T3.5/blob/main/docs/Risk/PBN__Risk_3256.md)
* [Lack of drug therapy options](https://github.com/mm80843/T3.5/blob/main/docs/Risk/PBN__Risk_1146.md)
* [Lack of access to pharmaceutical interventions](https://github.com/mm80843/T3.5/blob/main/docs/Risk/PBN__Risk_1158.md)
* [Identification of effective drug compounds](https://github.com/mm80843/T3.5/blob/main/docs/Risk/PBN__Risk_3045.md)
* [Insufficient non-pharmaceutical interventions](https://github.com/mm80843/T3.5/blob/main/docs/Risk/PBN__Risk_1603.md)
* [Inefficient medication delivery](https://github.com/mm80843/T3.5/blob/main/docs/Risk/PBN__Risk_2188.md)

## Mitigations of this risk

* [AI for drug discovery](https://github.com/mm80843/T3.5/blob/main/docs/RiskMitigation/PBN__RiskMitigation_656.md)

